Skip to main content

Advertisement

SpringerLink
Log in

Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK/IκB kinase dependent NF-κB-mediated promatrix metalloproteinase-9 activation

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

An Erratum to this article was published on 07 June 2007

Abstract

Osteopontin (OPN) is a secreted, non-collagenous, sialic-acid rich, glycosylated adhesive phospho- protein. Several highly metastatic transformed cells synthesized a higher level of OPN compared with non-tumorigenic cells. We have recently reported that OPN induces nuclear factor-κB (NF-κB)-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways. However, the molecular mechanism(s) by which OPN regulates pro-matrix metalloproteinase-9 (pro-MMP-9) activation and involvement of upstream kinases in regulation of these processes that ultimately control cell motility and tumor growth in murine melanoma cells are not well defined. Here we report that OPN induces αvβ3 integrin-mediated phosphorylation and activation of nuclear factor inducing kinase (NIK) and enhances the interaction between phosphorylated NIK and IκBα kinase α/β (IKKα/β) in B16F10 cells. Moreover, NIK is involved in OPN-induced phosphorylations of MEK-1 and ERK1/2 in these cells. OPN induces NIK-dependent NF-κB activation through ERK/IKKα/β-mediated pathways. Furthermore, OPN enhances NIK-regulated urokinase-type plasminogen activator (uPA) secretion, uPA-dependent pro-MMP-9 activation, and cell motility. Pretreatment of cells with anti-MMP-2 antibody along with anti-MMP-9 antibody drastically inhibited the OPN-induced cell migration and chemoinvasion, whereas cells pretreated with anti-MMP-2 antibody had no effect on OPN-induced pro-MMP-9 activation suggesting that OPN induces pro-MMP-2 and pro-MMP-9 activations through two distinct pathways. Taken together, NIK acts as crucial regulator in OPN-induced MAPK/IKK-mediated NF-κB-dependent uPA secretion and MMP-9 activation thereby controlling melanoma cell motility and chemoinvasion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Denhardt, D., Guo, X.: Osteopontin: A protein with diverse functions. FASEB J. 7, 1475–82 (1993)

    CAS  PubMed  Google Scholar 

  2. Oldberg, A., Franzen, A., Heinegard, D.: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc. Natl. Acad. Sci. USA 83, 8819–23 (1986)

    CAS  PubMed  Google Scholar 

  3. Panda, D., Kundu, G.C., Lee, B.I., Peri, A., Fohl, D., Chackalaparampil, I., Mukherjee, B.B., Li, X.D., Mukherjee, D.C., Seides, S., Rosenberg, J., Stark, K., Mukherjee, A.B.: Potential roles of osteopontin and alphav beta3 integrin in the development of coronery artery restenosis after angioplasty. Proc. Natl. Acad. Sci. USA 94, 9308–13 (1997)

    Article  CAS  PubMed  Google Scholar 

  4. Shanmugam, V., Chackalaparampil, I., Kundu, G.C., Mukherjee, A.B., Mukherjee, B.B.: Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry 36, 5729–38 (1997)

    Article  CAS  PubMed  Google Scholar 

  5. Senger, D.R., Perruzzi, C.A., Papadopoulos, A.: Elevated expression of secreted phosphoprotein I (osteopontin 2ar) as a consequence of neoplastic transformation. Anticancer Res. 9, 1291–9 (1989)

    CAS  PubMed  Google Scholar 

  6. Chamber, A.F., Behrend, E.I., Wilson, S.M., Denhardt, D.T.: Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic ras-transformed NIH3T3 cells. Anticancer Res. 12, 43–47 (1992)

    Google Scholar 

  7. Behrend, E.I., Craig, A.M., Wilson, S.M., Denhardt, D.T., Chamber, A.F.: Reduced malignancy of ras transformed NIH3T3 cells expressing antisense osteopontin, RNA. Cancer Res. 54, 832–7 (1994)

    CAS  PubMed  Google Scholar 

  8. Gardner, H.A., Berse, B., Senger, D.R.: Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 9, 2321–6 (1994)

    CAS  PubMed  Google Scholar 

  9. Philip, S., Bulbule, A., Kundu, G.C.: Osteopontin stimulates tumor growth and activation of pro-matrixmetalloproteinase-2 through nuclear factor-ΚB mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 276, 44926–35 (2001)

    Article  CAS  PubMed  Google Scholar 

  10. Philip, S., Kundu, G.C.: Osteopontin induces nuclear factor-ΚB mediated promatrix metalloproteinase-2 activation through IΚBα/IKK signaling pathways, and curcumin down-regulates these pathways. J. Biol. Chem. 278, 14487–97 (2003)

    Article  CAS  PubMed  Google Scholar 

  11. Das, R., Mahabeleshwar, G.H., Kundu, G.C.: Osteopontin stimulates cell motility and nuclear factor-ΚB mediated secretion of urokinase type plasminogen activator through phosphotidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J. Biol. Chem. 278, 28593–06 (2003)

    Article  CAS  PubMed  Google Scholar 

  12. Das, R., Mahabeleshwar, G.H., Kundu, G.C.: Osteopontin induces AP-1 mediated secreted of urokinase type plasminogen activator through c-Src-dependent Epidermal growth factor receptor transactivation in breast cancer cells. J. Biol. Chem. 279, 11051–64 (2004)

    Article  CAS  PubMed  Google Scholar 

  13. Rangaswami, H., Bulbule, A., Kundu, G.C.: Nuclear factor inducing kinase plays a crucial role in osteopontin induced MAPK/IKK dependent nuclear factor-ΚB mediated promatrix- metalloproteinase-9 activation. J. Biol. Chem. 279, 38921–35 (2004)

    Article  CAS  PubMed  Google Scholar 

  14. Rayet, B., Gelinas, C.: Aberrant Rel/NFΚB genes and activity in human cancer. Oncogene 18, 6938–47 (1999)

    Article  CAS  PubMed  Google Scholar 

  15. Sovak, M.A., Bellas, R.E., Kim, D.W., Zaneiski, G.J., Rojers, A.E., Traish, A.M., Sonenshein, G.E.: Aberrant nuclear factor-ΚB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952–60 (1997)

    Article  CAS  PubMed  Google Scholar 

  16. Palayoor, S.T., Youmell, M.Y., Caldrewood, S.K., Coleman, C.N., Price, B.D.: Constitutive activation of I kappa B kinase alpha and NF-kappa B in prostate cancer cells is inhibited by ibuprofen. Oncogene 18, 7389–94 (1999)

    Article  CAS  PubMed  Google Scholar 

  17. Baldwin, A.S.: The NF-kappa B and I kappa B proteins: New discoveries and inisights. Annu. Rev. Immunol. 14, 649–81 (1996)

    Article  CAS  PubMed  Google Scholar 

  18. Whiteside, S.T., Epinat, J.C., Rice, N.R., Israel, A.I.: kappa B epsilon, a novel member of the I kappa B family, controls Rel A and c rel NF-kappa B activity. EMBO J. 16, 1413–26 (1997)

    Article  CAS  PubMed  Google Scholar 

  19. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., Wallach, D.: MAP3K-related kinase involved in NF-kB induction by TNF, CD95 and IL-1. Nature 385, 540–44 (1997)

    Article  CAS  PubMed  Google Scholar 

  20. Legrand, C., Polette, M., Tournier, J.M., Bentzmann, S.D., Huet, E., Monteau, M., Birembaut, P.: uPA/ plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp. Cell Res. 264, 326–36 (2001)

    Article  CAS  PubMed  Google Scholar 

  21. Springman, E.B., Angleton, E.L., Birkedal-Hansen, H., Van Wart, H.E.: Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys 73 active site zinc complex in latency and a “cysteine-switch” mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364–8 (1990)

    CAS  PubMed  Google Scholar 

  22. Colier, I.E., Wilhelm, S.M., Eisen, A.Z., Marmer, B.L., Grant, G.A., Siltzer, J.L., Kronberger, A., He, C.S., Bauer, E.A., Goldberg, G.I.: H-Ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263, 6579–87 (1988)

    Google Scholar 

  23. Lee, K.A., Bindereif, A., Green, M.R.: A small scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene. Anal. Tech. 5, 22–31 (1988)

    Article  CAS  PubMed  Google Scholar 

  24. Yue, T.L., Mckenna, P.J., Ohlstein, E.H., Farach-Carson, M.C., Butler, W.T., Johanson, K., McDevitt, P., Feuerstein, G.Z., Stadel, J.M.: Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta-3 integrin. Exp. Cell Res. 214, 459–64 (1994)

    Article  CAS  PubMed  Google Scholar 

  25. Yu, Q., Stamenkovic, I.: Localization of matrix metalloproteinase-9 (MMP-9) to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes. and Dev. 13, 35–48 (1999)

    CAS  PubMed  Google Scholar 

  26. DiDonato, J., Hayakawa, M., Rothwarf, D.M., Zandi, E., Karin, M.: A cytokine-responsive IΚB kinase that activates the transcription factor NF-ΚB. Nature 388, 853–62 (1997)

    Google Scholar 

  27. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., Rothe, M.: Identification and characterization of and IΚB kinase. Cell 90, 373–83 (1997)

    Article  CAS  PubMed  Google Scholar 

  28. Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., Okumura, K.: Differential regulation of IΚB kinase α and β by two upstream kinases, NF-ΚB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA. 95, 3537–42 (1998)

    Article  CAS  PubMed  Google Scholar 

  29. Foehr, E.D., Bohuslav, J., Chen, L., DeNoronha, C., Geleziunas, R., Lin, X., O’Mahony, A., Greene, W.C.: The NF-ΚB-inducing kinase induces PC12 cell differentiation and prevents apoptosis. J. Biol. Chem. 275, 34021–24 (2000)

    Article  CAS  PubMed  Google Scholar 

  30. Maquoi, E., Frankenne, F., Noel, A., Krell, H.-W., Grams, F., Foidart, J.M.: Type IV collagen induces matrix metalloproteinase-2 activation in HT1080 fibrosarcoma cells. Exp. Cell Res. 261, 348–59 (2000)

    Article  CAS  PubMed  Google Scholar 

  31. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, R.M., Werb, Z.: MMP-9/gelatinase-B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411–22 (1998)

    Article  CAS  PubMed  Google Scholar 

  32. Lakka, S.S., Jasti, S.L., Gondi, C., Boyd, D., Chandrasekar, N., Dinh, D.H., Olivero, W.C., Gujrati, M., Rao, J.S.: Downregulation of MMP-9 in ERK mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21, 5601–8 (2002)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Center for Cell Science (NCCS), Pune, 411 007, India

    Hema Rangaswami, Anuradha Bulbule & Gopal C. Kundu

Authors
  1. Hema Rangaswami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anuradha Bulbule
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gopal C. Kundu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gopal C. Kundu.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s10719-007-9044-1.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rangaswami, H., Bulbule, A. & Kundu, G.C. Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK/IκB kinase dependent NF-κB-mediated promatrix metalloproteinase-9 activation. Glycoconj J 23, 221–232 (2006). https://doi.org/10.1007/s10719-006-7927-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-006-7927-1

Keywords

Search

Navigation